December 09, 2021
Back Page
41
12
For biopharma innovation to succeed and accelerate, companies must stop duplicating their efforts and share valuable information.
December 09, 2021
Features
41
12
Chief commercial officers gather for an insightful roundtable discussion anchored in the future of sales and marketing in light of new communication media brought on by the pandemic.
December 09, 2021
Features
41
12
Our annual report takes a look at pharma’s current investment in drug development, which this year demonstrates a focus on five important therapeutic areas of interest—Alzheimer’s disease, ophthalmology, NASH, anti-infectives, and opioids.
December 09, 2021
Executive Profile
41
12
After two decades at the forefront of hematology and oncology drug development, AbbVie’s vice president and global head of oncology clinical development, Mohamed Zaki, MD, PhD, is more hopeful than ever about recent advances in the space.
December 09, 2021
Finance
41
12
Industry growth in innovation could spark financial rebound.
December 09, 2021
Managed Markets
41
12
Potential for quality equivalent to economies of scale.
December 09, 2021
Technology
41
12
Critics proclaim that recent RWD guidance issued by FDA still has a good number of gaps to fill and may take some time to accomplish.
December 09, 2021
Leadership
41
12
It’s time to see how you’re doing with putting words into action.
December 09, 2021
Global Report
41
12
Lack of IP management plagues recent regulatory discussions.
December 09, 2021
Washington Report
41
12
COVID vaccine development highlights need for modernization.
December 09, 2021
From the Editor
41
12
COVID pandemic brings increased attention to other infectious diseases.
December 09, 2021
Issue PDF
41
12
Click the title above for a link to open the Pharmaceutical Executive December 2021 issue in an interactive PDF format.